Henderson, Nevada Saturday, September 27, 2025, 17:00 Hrs [IST] ...
VarmX receives phase 1 waiver from Japanese medicines regulator PMDA for lead asset VMX-C001: Leiden, The Netherlands Saturday, September 27, 2025, 18:00 Hrs [IST] VarmX, a biotec ...
US FDA approves Eli Lilly’s Inluriyo for adults with ER+, HER2-, ESR1-mutated advanced or metastatic breast cancer: Indianapolis Saturday, September 27, 2025, 15:00 Hrs [IST] El ...
NIH establishes nation's first dedicated organoid development centre to reduce reliance on animal modelling: Bethesda, Maryland Saturday, September 27, 2025, 16:00 Hrs [IST] The N ...
Nandita Vijayasimha, Bengaluru Saturday, September 27, 2025, 08:00 Hrs [IST] ...
AMMOI workshop highlights industry challenges and calls for medicinal plants cultivation support: Peethaambaran Kunnathoor, Chennai Saturday, September 27, 2025, 08:00 Hrs [IST] T ...
CCSEA clarifies purchase of beagle dogs from breeders is applicable only for breeding purpose: Gireesh Babu, New Delhi Saturday, September 27, 2025, 08:00 Hrs [IST] The Committee ...
Veterinary vaccine manufacturers in the country have come together to announce the formation of the Veterinary Vaccine India Manufacturers Association (VVIMA), a not-for-profit organization that will ...
India’s journey to a billion-dollar drug may not be about groundbreaking science, but rather solving a complex puzzle of access, financing, and insurance. With over 100 million people living with ...
Indian pharma upset on US President Donald Trump’s 100% tariff on branded medicines: Nandita Vijayasimha, Bengaluru Saturday, September 27, 2025, 08:00 Hrs [IST] The Indian phar ...
Experts at 5th NPW stress on need to strengthen ADR reporting for patient safety: Shardul Nautiyal, Mumbai Saturday, September 27, 2025, 08:00 Hrs [IST] The 5th National Pharmacov ...
RetinalGenix Technologies advances patent portfolio to monitor ocular and systemic disease care: Apollo Beach, Florida Saturday, September 27, 2025, 13:00 Hrs [IST] RetinalGenix T ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results